Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells

Publisher： Karger

E-ISSN： 1423-0399|86|3|346-354

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.86, Iss.3, 2011-01, pp. : 346-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells

By  

Urologia Internationalis, Vol. 87, Iss. 1, 2011-05 ,pp. : 105-113

Karger

Access to resources Recommend Favorite

Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural Effusions

By  

Oncology, Vol. 90, Iss. 5, 2016-04 ,pp. : 280-288

Karger

Access to resources Recommend Favorite

Protein Kinase C Is Involved in Arsenic Trioxide-Induced Apoptosis and Inhibition of Proliferation in Human Bladder Cancer Cells

By  

Urologia Internationalis, Vol. 82, Iss. 2, 2009-03 ,pp. : 214-221

Karger

Access to resources Recommend Favorite

Glycogen synthase kinase‐3 inhibitor AR‐A014418 suppresses pancreatic cancer cell growth via inhibition of GSK‐3‐mediated Notch1 expression

By  

HPB, Vol. 17, Iss. 9, 2015-09 ,pp. : 770-776

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Phosphatidylinositol 3-Kinase Signaling Pathways in Pancreatic Cancer

By  

Pancreatology, Vol. 11, Iss. 2, 2011-05 ,pp. : 252-260

Karger

Access to resources Recommend Favorite